cholestyramine resin Powder for Oral Suspension
RxNorm concept 1801266, clinical dose form (scdf).
- RxCUI
- 1801266
- Term type
- Clinical dose form (SCDF)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1801266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Powder for Oral Suspension (DF, has dose form)
- cholestyramine resin (IN, has ingredient)
- cholestyramine resin Powder for Oral Suspension [Questran] (SBDF, has tradename)
- cholestyramine resin Powder for Oral Suspension [Prevalite] (SBDF, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1801266 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1801266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1801266. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.